Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01373177 · ClinicalTrials.gov registry record · NA

Differences Between the Bayley-II and the Bayley-III in Very Preterm Infants at 2 Years

A NA study of Infant Development, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
NA
Development phase
119
Enrollment target
1
Study location

NCT01373177 is a NA study of Infant Development that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 119 participants, below the 399-participant average among 30 other Infant Development trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01373177, a NA study of Infant Development, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
NA
Development phase
119 participants
Enrollment target
1
Study location

Study Summary

The objective of this randomized study is to test the hypothesis that scores on the Bayley Scales of Infant Development-III (Bayley-III) are higher than scores on the Bayley Scales of Infant Development-II (BSID-II) in the same group of infants who were born very preterm.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Bayley Scales of Infant Development-II
  • DIAGNOSTIC_TEST Bayley Scales of Infant Development-III

Study Locations (1)

Pennsylvania

  • The Children's Hospital of Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 119 participants
Start Date 2011-01
Est. Completion 2015-02
Phase NA

Sponsor

Children's Hospital of Philadelphia

431 total trials

What the Registry Record Tells You About NCT01373177

The ClinicalTrials.gov registry entry for NCT01373177 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 399-participant average among 30 other Infant Development trials with a reported enrollment target (70% lower). The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infant Development appearing as the primary indexed condition, and to 2 interventions - of which Bayley Scales of Infant Development-II is the first listed.

NCT01373177 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01373177 about?

NCT01373177 is a clinical study titled "Differences Between the Bayley-II and the Bayley-III in Very Preterm Infants at 2 Years". The objective of this randomized study is to test the hypothesis that scores on the Bayley Scales of Infant Development-III (Bayley-III) are higher than scores on the Bayley Scales of Infant Development-II (BSID-II) in the same group of infants who were born very preterm.

What is the current status of trial NCT01373177?

This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2011-01. Estimated completion is 2015-02.

What conditions does trial NCT01373177 study?

This clinical trial studies the following conditions: Infant Development.

What interventions are being tested in trial NCT01373177?

The interventions under investigation include: Bayley Scales of Infant Development-II (DIAGNOSTIC_TEST), Bayley Scales of Infant Development-III (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT01373177?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01373177 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infant Development

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.